"Recall Issued for Birth Control Pills Over Reduced Effectiveness Concerns"

Pharmaceutical company Lupin is recalling two batches of the birth control pill Tydemy due to potential reduced effectiveness. Tests revealed decreased levels of ascorbic acid and high levels of a known impurity in the pills. The FDA has warned that the low levels of ascorbic acid could impact the pill's ability to prevent pregnancy. No adverse events have been reported so far. Patients are advised to contact their healthcare provider for alternative treatment options. The affected batches were distributed between June 2022 and May 2023.